| Title |
Withanone from Withania somnifera Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model
|
|---|---|
| Published in |
Drug Design, Development and Therapy, March 2021
|
| DOI | 10.2147/dddt.s292805 |
| Pubmed ID | |
| Authors |
Acharya Balkrishna, Subarna Pokhrel, Hoshiyar Singh, Monali Joshi, Vallabh Prakash Mulay, Swati Haldar, Anurag Varshney |
X Demographics
The data shown below were collected from the profiles of 294 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 122 | 41% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Nepal | 1 | <1% |
| Central African Republic | 1 | <1% |
| Unknown | 168 | 57% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 281 | 96% |
| Practitioners (doctors, other healthcare professionals) | 7 | 2% |
| Science communicators (journalists, bloggers, editors) | 3 | 1% |
| Scientists | 3 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 121 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 12% |
| Student > Bachelor | 11 | 9% |
| Student > Master | 10 | 8% |
| Student > Postgraduate | 8 | 7% |
| Student > Doctoral Student | 7 | 6% |
| Other | 24 | 20% |
| Unknown | 47 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 16 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 12% |
| Medicine and Dentistry | 14 | 12% |
| Agricultural and Biological Sciences | 6 | 5% |
| Chemistry | 5 | 4% |
| Other | 14 | 12% |
| Unknown | 52 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 251. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2024.
All research outputs
#149,867
of 26,017,215 outputs
Outputs from Drug Design, Development and Therapy
#14
of 2,296 outputs
Outputs of similar age
#4,649
of 455,062 outputs
Outputs of similar age from Drug Design, Development and Therapy
#1
of 56 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,296 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,062 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.